Faye
Faye Raises $50M Series C for Autonomous Traveler Care
Faye announced $50M in Series C financing on August 5, 2026. Faye raised a $50 million Series C led by Madrona to accelerate AI investments, partnerships and expansion into new markets for its travel protection platform.
Round details
The financing includes backing from Madrona, BRM, Portage, F2 Venture Capital, Viola Ventures, Lumir Ventures. The company did not publish a valuation with the announcement.
- Round: Series C
- Capital announced: $50M
- Total funding reported: $100M
How the company plans to use the capital
Faye said it will use the capital to accelerate its next phase of growth, including expansion into new markets, growing partnerships with online travel agencies, airlines, cruise lines and other travel brands, and doubling down on AI to make underwriting, traveler assistance and claims faster, smarter and increasingly autonomous. The investment will also expand the company’s travel fintech capabilities.
Why this matters for GTM teams
Madrona led the round, with participation from BRM and existing investors Portage, F2 Venture Capital, Viola Ventures and Lumir Ventures, bringing Faye’s total funding to $100M.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Faye Series C announcement.
Company Info
Investors (6)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started